T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Saturday. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

Shares of NASDAQ TTOO opened at $0.18 on Friday. The business’s 50 day moving average price is $0.27 and its two-hundred day moving average price is $1.27. T2 Biosystems has a twelve month low of $0.06 and a twelve month high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.